Glutamates

Type: Keyphrase

Name: Glutamates

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Applied Materials Inc

Reports Outline Materials Science Study Results from M. Ashi. . .

Reports Outline Materials Science Study Results from M. Ashiuchi et alMaterials ScienceNewsRx.comBy a News Reporter-Staff News Editor at Life Science Weekly -- Current study results on Materials Science have been published. According to news reporting ... [Published Equities.com - Apr 25 2013]

Entities: Materials Science, Applied Materials Inc, Osaka, Thermoplastic

Quotes

News editors obtained the following quote from the background information supplied by the inventors: "Glatiramer acetate (also known as copolymer-1 and marketed as the active ingredient in COPAXONE.RTM. by Teva Pharmaceutical Industries Ltd., Israel) is used in the treatment of the relapsing-remitting form of multiple sclerosis (RRMS). According to the COPAXONE.RTM. product label, glatiramer acetate (GA) consists of the acetate salts of synthetic polypeptides, containing four naturally occurring amino acids: L-glutamic acid, L-alanine, L-tyrosine, and L-lysine with a reported average molar fraction of 0.141, 0.427, 0.095, and 0.338, respectively. Chemically, glatiramer acetate is designated L-glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt). Its structural formula is:"

Researchers Submit Patent Application, "Analysis of Amino Ac. . . [Published Equities.com - May 01 2013]